Filing Details

Accession Number:
0001209191-19-029970
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-15 16:05:29
Reporting Period:
2019-05-13
Accepted Time:
2019-05-15 16:05:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296999 David Arkowitz C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-13 4,000 $11.99 86,924 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction reported was $11.99, and the range of prices were between $11.9877 and $11.9879. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.